Neumonía por Pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn / Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease
Rev. chil. infectol
; Rev. chil. infectol;34(5): 518-519, oct. 2017. graf
Article
in Es
| LILACS
| ID: biblio-1042641
Responsible library:
CL1.1
ABSTRACT
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Pneumonia, Pneumocystis
/
Gastrointestinal Agents
/
Crohn Disease
/
Infliximab
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
Limits:
Female
/
Humans
Language:
Es
Journal:
Rev. chil. infectol
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2017
Document type:
Article
Affiliation country:
Chile
Country of publication:
Chile